Filed: 5/15/2025ACC: 0001415889-25-013106
📋 What this filing means
SAMSARA BIOCAPITAL, LLC filed this quarterly 13F‑HR report disclosing 37 equity positions with a total reported market value of $560.81M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
37
Positions
$560.81M
Total AUM (reported)
66.41M
Total Shares
Allocation by class
COM$526.86M93.9%
COMMON STOCK$8.87M1.6%
COM SHS$7.58M1.4%
CL A$4.11M0.7%
CL A NEW$3.58M0.6%
COM NEW$3.56M0.6%
COM CL A$3.54M0.6%
Portfolio Concentration
Top 3$362.50M64.6%
4–10$121.57M21.7%
11–25$72.05M12.8%
Rest$4.69M0.8%
Top 3 weight
64.6%
Top 10 weight
86.3%
Voting Authority Distribution
Total shares with voting rights: 66.41M
Sole
Full voting authority
66.41M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole37
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings37
Rows:
SCHOLAR ROCK HLDG CORP
SOLEShares5.61M
TypeSH
Market value$180.45M
32.18%
Sole
5.61M
Shared
0.00
None
0.00
KALARIS THERAPEUTICS INC
SOLEShares11.45M
TypeSH
Market value$91.93M
16.39%
Sole
11.45M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
SOLEShares5.67M
TypeSH
Market value$90.12M
16.07%
Sole
5.67M
Shared
0.00
None
0.00
NEUROGENE INC
SOLEShares1.72M
TypeSH
Market value$20.11M
3.59%
Sole
1.72M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares3.27M
TypeSH
Market value$20.06M
3.58%
Sole
3.27M
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC NE
SOLEShares679.49K
TypeSH
Market value$19.02M
3.39%
Sole
679.49K
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares3.15M
TypeSH
Market value$18.23M
3.25%
Sole
3.15M
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
SOLEShares4.42M
TypeSH
Market value$17.97M
3.20%
Sole
4.42M
Shared
0.00
None
0.00
LENZ THERAPEUTICS INC
SOLEShares526.39K
TypeSH
Market value$13.53M
2.41%
Sole
526.39K
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares2.07M
TypeSH
Market value$12.65M
2.26%
Sole
2.07M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares135.28K
TypeSH
Market value$8.87M
1.58%
Sole
135.28K
Shared
0.00
None
0.00
ZYMEWORKS INC
SOLEShares666.67K
TypeSH
Market value$7.94M
1.42%
Sole
666.67K
Shared
0.00
None
0.00
AVADEL PHARMACEUTICALS PLC
SOLEShares967.53K
TypeSH
Market value$7.58M
1.35%
Sole
967.53K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares138.12K
TypeSH
Market value$7.32M
1.30%
Sole
138.12K
Shared
0.00
None
0.00
NKARTA INC
SOLEShares3.77M
TypeSH
Market value$6.93M
1.24%
Sole
3.77M
Shared
0.00
None
0.00
GOSSAMER BIO INC
SOLEShares6.13M
TypeSH
Market value$6.74M
1.20%
Sole
6.13M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares2.52M
TypeSH
Market value$6.23M
1.11%
Sole
2.52M
Shared
0.00
None
0.00
CONTINEUM THERAPEUTICS INC
SOLEShares588.82K
TypeSH
Market value$4.11M
0.73%
Sole
588.82K
Shared
0.00
None
0.00
VTV THERAPEUTICS INC
SOLEShares206.78K
TypeSH
Market value$3.58M
0.64%
Sole
206.78K
Shared
0.00
None
0.00
ONKURE THERAPEUTICS INC
SOLEShares824.15K
TypeSH
Market value$3.54M
0.63%
Sole
824.15K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares241.40K
TypeSH
Market value$2.81M
0.50%
Sole
241.40K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares425K
TypeSH
Market value$2.66M
0.47%
Sole
425K
Shared
0.00
None
0.00
SUTRO BIOPHARMA INC
SOLEShares2.20M
TypeSH
Market value$1.43M
0.25%
Sole
2.20M
Shared
0.00
None
0.00
INOZYME PHARMA INC
SOLEShares1.56M
TypeSH
Market value$1.42M
0.25%
Sole
1.56M
Shared
0.00
None
0.00
ARTIVA BIOTHERAPEUTICS INC
SOLEShares291.67K
TypeSH
Market value$875.0K
0.16%
Sole
291.67K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SCHOLAR ROCK HLDG CORPSOLE | COM | 5.61M | SH | $180.45M 32.18% | 5.61M | 0.00 | 0.00 |
KALARIS THERAPEUTICS INCSOLE | COM | 11.45M | SH | $91.93M 16.39% | 11.45M | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCSOLE | COM | 5.67M | SH | $90.12M 16.07% | 5.67M | 0.00 | 0.00 |
NEUROGENE INCSOLE | COM | 1.72M | SH | $20.11M 3.59% | 1.72M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 3.27M | SH | $20.06M 3.58% | 3.27M | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INC NESOLE | COM | 679.49K | SH | $19.02M 3.39% | 679.49K | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 3.15M | SH | $18.23M 3.25% | 3.15M | 0.00 | 0.00 |
CARGO THERAPEUTICS INCSOLE | COM | 4.42M | SH | $17.97M 3.20% | 4.42M | 0.00 | 0.00 |
LENZ THERAPEUTICS INCSOLE | COM | 526.39K | SH | $13.53M 2.41% | 526.39K | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 2.07M | SH | $12.65M 2.26% | 2.07M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 135.28K | SH | $8.87M 1.58% | 135.28K | 0.00 | 0.00 |
ZYMEWORKS INCSOLE | COM | 666.67K | SH | $7.94M 1.42% | 666.67K | 0.00 | 0.00 |
AVADEL PHARMACEUTICALS PLCSOLE | COM SHS | 967.53K | SH | $7.58M 1.35% | 967.53K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 138.12K | SH | $7.32M 1.30% | 138.12K | 0.00 | 0.00 |
NKARTA INCSOLE | COM | 3.77M | SH | $6.93M 1.24% | 3.77M | 0.00 | 0.00 |
GOSSAMER BIO INCSOLE | COM | 6.13M | SH | $6.74M 1.20% | 6.13M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 2.52M | SH | $6.23M 1.11% | 2.52M | 0.00 | 0.00 |
CONTINEUM THERAPEUTICS INCSOLE | CL A | 588.82K | SH | $4.11M 0.73% | 588.82K | 0.00 | 0.00 |
VTV THERAPEUTICS INCSOLE | CL A NEW | 206.78K | SH | $3.58M 0.64% | 206.78K | 0.00 | 0.00 |
ONKURE THERAPEUTICS INCSOLE | COM CL A | 824.15K | SH | $3.54M 0.63% | 824.15K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 241.40K | SH | $2.81M 0.50% | 241.40K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 425K | SH | $2.66M 0.47% | 425K | 0.00 | 0.00 |
SUTRO BIOPHARMA INCSOLE | COM | 2.20M | SH | $1.43M 0.25% | 2.20M | 0.00 | 0.00 |
INOZYME PHARMA INCSOLE | COM | 1.56M | SH | $1.42M 0.25% | 1.56M | 0.00 | 0.00 |
ARTIVA BIOTHERAPEUTICS INCSOLE | COM | 291.67K | SH | $875.0K 0.16% | 291.67K | 0.00 | 0.00 |
Page 1 of 2